Daewoong Pharmaceutical exports diabetes treatment ‘Enblo’ to the Middle East and Africa
⚡ Quick Summary
(Seoul = Yonhap News) Reporter Shin Seon-mi = Daewoong Pharmaceutical [069620] enters the Middle East and Africa (MENA) market with its diabetes treatment drug 'Enblo' (ingredient name: inavogliflozin)...
🗞️ 2 sources covered this story
📰 Related Articles
Samsung, SK, Celltrion, etc. invested 392 trillion won in Chungcheong area
Khan
[Sejong News] Recruiting 15 young farmers to participate in ‘Overseas Advanced Agricultural Field Training’
Yonhap
Ulju-gun, overhaul all remnants of illegal banners in urban areas
Yonhap
"China's automobile exports from January to May exceeded 4 million units... Possibility of reaching 10 million units this year."
Yonhap
KB Securities produces voice phishing prevention video to celebrate ‘Consumer Protection Day’
Yonhap